We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Bayer has signed a definitive agreement to sell its Animal Health unit to US-based Elanco Animal Health for a total of $7.6bn, in a bid to focus on its core life sciences businesses.